Anuh Pharma Ltd

To consider and approve the Audited Financial Results for the Financial Year ending 31st March 2025 issue of Bonus Equity shares in the ration of 1:1 i.e. 1 (One) equity shares of ? 5.00/- each for every 1 (One) full paid-up equity share of ? 5.00/- recommendation of Dividend for the Financial Year 2024-25 subject to the approval of the members.